Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jun 17, 2015
This talk was organized by the Czech Psychedelic Society. It was held in Collegium Maximum at the Faculty of Law, Charles University, Prague, 25th April 2015.
Psychedelic drugs have been used for millennia by certain cultures and are now being used by scientists and doctors in contemporary science and medicine to understand the brain and treat certain mental disorders such as depression. Dr Robin Carhart-Harris will describe his research with these unusual compounds, which includes functional brain imaging studies with LSD and psilocybin (aka 'magic mushrooms') and an ongoing study investigating whether psilocybin can be used to treat depression.
This event was held by the Czech Psychedelic Society, a newly founded association of students and professionals with interest in the scientific and therapeutic use of psychedelic drugs. We put an emphasis on destigmatization of psychedelics on the basis of current empirical knowledge. We want to open a discussion regarding potential use of psychedelics, to regularly invite leading scientists in the field of psychedelic research and, thus, follow the legacy of the Czech Republic as one of the centers of psychedelic research in 1960s.
Dr. Robin Carhart-Harris is a leading neuroscientist, Imperial College London, who is the first person in the UK who has conducted LSD study on human subjects after more than 40 years. His originally psychoanalytic orientation led him to interest in studies on uncounsciousness with use of psychedelics and neuroimaging methods. Dr.Carhart-Harris has done studies on psilocybin, MDMA, and newly LSD. He examines its influences on functioning of brain and looking into possibilities of therapeutic use in a treatment of psychological disorders or addictions. Moreover, he is an author of the Entropic Brain theory which provides a connection between modern neurobiology, psychoanalysis and theoretical physics.